Market Research Logo

Immunodiagnostic Market in China 2015-2019

About immunodiagnostics

Immunodiagnostics is a class of in vitro diagnostics that utilizes antigen-antibody reaction as its primary means of detecting infectious diseases, tumors, diabetes, proteins, therapeutic drugs, and allergens. Immunodiagnostics tests are analytical methods that require different immunodiagnostics instruments and antibodies as reagents against the desired antigens to be detected. The test results are used to diagnosis diseases, and they have widespread clinical applications. Immunodiagnostics tests are also helpful in the field of forensic science, environmental science, and food analysis.

The rate of chronic diseases and infections in China has increased significantly in the past few years. Therefore, there is an increase in the demand for immunodiagnostics tests to detect diseases at an early stage, driving the immunodiagnostics market in China.

Technavio's analysts forecast the immunodiagnostics market in China to grow at a CAGR of 16.6% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the immunodiagnostics market in China for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of immunodiagnostic test products. Based on technique, the market is segmented into the following:

  • ELISA
  • CLIA
  • Others (immunofluorescent test, radio immunoassay, immunoelectrophoresis, flow cytometry, and lateral flow immunoassay)
Based on product, the market is segmented into the following:
  • Reagents
  • Instruments
Technavio's report, Immunodiagnostic Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the immunodiagnostic market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Diagnostics
  • Beckman Coulter Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
Other prominent vendors
  • BioSino Bio-technology & Science
  • DiaSorin
  • Immunodiagnostic System Holdings (IDS)
  • Mindray Medical International
  • Shanghai Kehua Bio-engineering
  • Sichuan Maccura Biotechnology
Key market driver
  • Widening of insurance coverage
  • For a full, detailed list, view our report
Key market challenge
  • Declining imports
  • For a full, detailed list, view our report
Key market trend
  • Growing mergers and acquisitions
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Immunodiagnostic Market in China 2015-2019
Technavio recognizes the following companies as the key players in the Immunodiagnostic Market in China: Abbott Diagnostics, Beckman Coulter Diagnostics, Roche Diagnostics and Siemens Healthcare Diagnostics
Other Prominent Vendors in the market are: BioSino Bio-technology & Science, DiaSorin, Immunodiagnostic System Holdings (IDS), Mindray Medical International, Shanghai Kehua Bio-engineering and Sichuan Maccura Biotechnology
Commenting on the report, an analyst from Technavio’s team said: “The immunodiagnostics market in China is an attractive market for the foreign players, owing to the increasing Chinese population, increasing urbanization, accelerated rate of diseases, and increasing aging population. There are many local players in this market, but most lack quality due to less technology resources and funding. Well-established multinational companies are preferred worldwide due to their reputations and perceived brand value. In spite of having an edge on local players in terms of quality, diverse product portfolios, and brand value, entering the Chinese market is difficult for the international players because of the regulating policies by the government. Partnerships or acquisitions can help the multinationals eliminate the entry barrier. Thus, M&A has become an increasing trend in China.”
According to the report, China ranks first worldwide for its population. Urbanization in China is resulting in lifestyle changes, including unhealthy eating habits and smoking, which lead to an increase in health issues such as obesity, diabetes, cardiac problems, and cancer. Access to healthcare services is important and can be improved by providing insurance and coverage. Healthcare in China is associated with high out-of-pocket payments; however, the government of China is trying to provide universal coverage through its reforms and is encouraging private participation as the population is increasing every year. According to China's healthcare system reforms, around two thirds of the budget will be allocated to subsidized insurance plans, reducing out-of-pocket payments.
Further, the report states that decline in imports of medical devices will reduce the revenue generation of the foreign-based players from China.

Companies Mentioned

Abbott Diagnostics, Beckman Coulter Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, BioSino Bio-technology & Science, DiaSorin, Immunodiagnostic System Holdings (IDS), Mindray Medical International, Shanghai Kehua Bio-engineering, Sichuan Maccura Biotechnology

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Insurance coverage and reimbursement in China
    • Table Health insurance system in China
  • Regulatory landscape
    • Table Regulatory process for the approval of medical devices
    • Table Registration process of the IVD products in China
  • Diagnostics distribution network in China
    • Table Diagnostics dealers for clinical institutes in China 2013
  • Market landscape
    • Market overview
      • Table Immunodiagnostics market in China
    • Market size and forecast
      • Table Immunodiagnostics market in China 2014-2019 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • Table Immunodiagnostics market in China by product type
    • Table Segmentation of immunodiagnostics market in China by product type 2014
    • Table Segmentation of the market by product type 2014-2019
    • Immunodiagnostic reagents market in China
      • Table Immunodiagnostic reagents market in China 2014-2019 ($ billions)
    • Immunodiagnostic instruments market in China
      • Table Immunodiagnostic instruments market in China 2014-2019 ($ billions)
  • Market segmentation by techniques
    • Table Segmentation of the immunodiagnostics market in China by techniques
    • ELISA (Enzyme linked immunosorbent assay)
      • Table Immunodiagnostics market for ELISA in China 2014-2019 ($ millions)
    • Chemiluminescence immunoassay
      • Table Immunodiagnostics market for CLIA in China 2014-2019 ($ millions)
    • Other techniques
      • Table Immunodiagnostics market for other techniques in China 2014-2019 ($ millions)
      • Table Market segmentation by techniques in China 2014-2019
  • Market drivers
    • Widening of insurance coverage
    • Increase in joint ventures
    • High prevalence of chronic diseases and infections
    • Government measures for improving healthcare facilities
    • Increasing privatization in the healthcare sector
    • Increase in demand due to removal of medicine mark-ups
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Declining imports
    • Promotion of local manufacturing
    • Threat to protection of patents
    • Stringent regulatory policies
    • Pricing pressure through price ceilings
    • Uneven reimbursement policies
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Increase in M&A
    • Increasing usage of chemiluminiscence immunoassay
    • Increase in POC concept
    • Shift towards automation
  • Vendor landscape
    • Competitive scenario
    • Key prominent vendors
      • Table Roche Diagnostics: Key takeaways
      • Table Abbott Diagnostics: Key takeaways
      • Table Siemens Healthcare: Key takeaways
      • Table Beckman Coulter: Key takeaways
    • Other prominent vendors
  • Key vendor analysis
    • Roche Diagnostics
    • Abbott Diagnostics
      • Table Abbott Diagnostics: Key business offerings
    • Siemens Healthcare
    • Beckman Coulter
      • Table Beckman Coulter: Business segmentation
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report